Our von Hippel-Lindau Program, one of Stanford Health Care’s Neurogenetic Cancer Programs, brings together specialists from across Stanford Health Care to match your unique needs. This approach ensures you receive coordinated, personalized care and support to help you manage this complex condition.
Von Hippel-Lindau Syndrome (VHL)
Our doctors provide routine screening to identify VHL-related tumors early. You receive complete, multispecialty treatment using the latest technology.
Von Hippel-Lindau VHL screening